focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.76
Bid: 5.52
Ask: 6.00
Change: -0.65 (-10.14%)
Spread: 0.48 (8.696%)
Open: 6.41
High: 0.00
Low: 0.00
Prev. Close: 6.41
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Fri, 19th Jun 2015 05:21

UK AGM, EGM Calendar
Friday, June 19
Charlemagne Capital
Eland Oil and Gas
Avocet Mining
Horizon Discovery
Peninsular Gold
W Resources
Iofina
NextEnergy Solar Fund
Monday, June 22
Synairgen
Tarsus Group
Inspired Capital
Utima Networks
NetScientific
Tuesday, June 23
Coca-Cola HBC
Velocys
Blackrock Emerging Europe
Royal Bank of Scotland Group 
Scottish Mortgage Investment Trust
Universe Group
Saga
Bellzone Mining
Edenville Energy
Norcon
Tangent Communications
Wednesday, June 24
Oxford Pharmascience 
UMC Energy 
London & Associated Properties
Braemar Shipping Services
Pacifics Assets Trust
Greka Drilling
Condor Gold
Thursday, June 25
3i Group
Science In Sport
Union Jack Oil
Richoux Group
BH Macro
Afren
British & American Investment Trust
Helios Underwriting
First Derivatives
Gresham House
Liberty Global
Lifeline Scientific
Borders & Southern Perloeum
Sphere Medical Holding 
Stobart Group
Akers Bioscience
Faroe Petroleum
Symphony Environmental
 
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2015 07:42

Synairgen Signs Research Collaboration Deal With Australia's Pharmaxis

Read more
22 Jul 2015 10:44

AstraZeneca starts next phase of testing on Synairgen asthma drug

(ShareCast News) - Synairgen announced AstraZeneca started another phase of testing on its asthma drug. AIM listed Synairgen said AstraZeneca begun its Phase IIa trial of the drug AZD9412 and expected results in early 2017. AstraZeneca would test 220 asthma patients whose conditions were exacerbate

Read more
22 Jul 2015 07:00

Synairgen Says AstraZeneca Begins Phase IIa Trial In Severe Asthma

Read more
22 Jun 2015 07:28

LONDON BRIEFING: Stocks Surge On Optimism For Greek Debt Deal

Read more
22 Jun 2015 05:13

AGM, EGM Calendar - Week Ahead

Read more
19 Jun 2015 15:14

AGM, EGM Calendar - Week Ahead

Read more
18 Jun 2015 15:06

AGM, EGM Calendar - Week Ahead

Read more
18 Jun 2015 05:27

AGM, EGM Calendar - Week Ahead

Read more
17 Jun 2015 14:56

AGM, EGM Calendar - Week Ahead

Read more
17 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more
16 Jun 2015 15:03

AGM, EGM Calendar - Week Ahead

Read more
16 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more
15 Jun 2015 14:52

AGM, EGM Calendar - Week Ahead

Read more
3 Mar 2015 08:38

Synairgen Swings To 2014 Pretax Profit On AstraZeneca Licence Deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.